This is a guest post from Cliff Cramer, Director of the Healthcare and Pharmaceutical Management Program at Columbia Business School. Do you have a response to Cramer’s post? Post them in the comments section below. Multi-national pharmaceutical and medical technology companies will increase their investments in emerging markets, notably China and India, to access cost […]
Click here for reuse options!
Copyright 2009 Biotechblog